Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 6/20 | 0.65 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.65 |
| ▸ | BCL2L1 | Q07817 | 5/20 | 0.65 |
| ▸ | BAK1 | Q16611 | 5/20 | 0.65 |
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.65 |
| ▸ | PPARA | Q07869 | 3/20 | 0.65 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.65 |
| ▸ | EP300 | Q09472 | 2/20 | 0.65 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.65 |
| ▸ | PPARG | P37231 | 2/20 | 0.65 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.65 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.65 |
| ▸ | F7 | P08709 | 3/20 | 0.56 |
| ▸ | F3 | P13726 | 3/20 | 0.56 |
| ▸ | MMP2 | P08253 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5586821 | 0.98 | BID (0.68) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5587592 | 0.98 | BID (0.68) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5194899 | 0.95 | BID (0.58) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5589092 | 0.90 | BID (0.58) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5589657 | 0.90 | BID (0.58) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5587965 | 0.90 | BID (0.58) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5587527 | 0.90 | BID (0.58) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5588742 | 0.90 | BID (0.58) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5588106 | 0.90 | BID (0.58) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5586882 | 0.90 | BID (0.58) | BIDMCL1BCL2L1BAK1KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240110206-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2024-04-04 | — | — | US | disclosed |
| EP-4229190-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | Ginkgo Bioworks, Inc. (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2022081615-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| EP-3956462-A1 | OLIVETOL SYNTHASE VARIANTS AND METHODS FOR PRODUCTION OF OLIVETOLIC ACID AND ITS ANALOG COMPOUNDS | Genomatica, Inc. (US) | 2022-02-23 | — | — | EP | disclosed |
| WO-2021034848-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2021-02-25 | — | — | WO | disclosed |
| WO-2020214951-A1 | OLIVETOL SYNTHASE VARIANTS AND METHODS FOR PRODUCTION OF OLIVETOLIC ACID AND ITS ANALOG COMPOUNDS | GENOMATICA, INC. (US) | 2020-10-22 | — | — | WO | disclosed |
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | ZHAO BAIYI | 2006-02-16 | — | — | US | disclosed |
| EP-1620447-A1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | Exxonmobil Chemical Patents Inc. (US) | 2006-02-01 | — | — | EP | disclosed |
| WO-2003102006-A1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | COMT, CD69, SPR | BID 114/4885MCL1 3385/4885BCL2L1 2630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.